TAKEDA PHARMACEUTICALS AMERICA INC

Lobbying client · District of Columbia · filed 2026 to 2026

Pharmaceutical Manufacturing

$80,000 Reported spend

3 Filings counted

1 Firms hired

2 Bills named

Spend is reported income plus in-house expenses across 3 filings. Everything on this page is grouped by the client's LDA id (73763), not by name.

Firms hired 1

FARRAGUT PARTNERS LLP $80,000 3 filings

Bills named in these filings 2

HR 7299
To designate the facility of the United States Postal Service located at 2600 Michigan Avenue in Kissimmee, F…

2 filings
HR 4299
Protecting Patient Access to Cancer and Complex Therapies Act

1 filing

Reported by year 1 year

2026 $80,000 3 filings

Issues lobbied 1

Health Issues 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 2

HOUSE OF REPRESENTATIVES 2
SENATE 2

Recent filings 3 total

Q2

FARRAGUT PARTNERS LLP

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $40,000 income · posted Jul 20, 2026

View → Q1

FARRAGUT PARTNERS LLP

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $40,000 income · posted Jul 1, 2026

View → RR

FARRAGUT PARTNERS LLP

1st Quarter (Jan 1 - Mar 31) 2026 · posted Jun 30, 2026

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.